Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials
Cardiovascular disease (CVD) is one among the major causes of mortality all round the globe. Several anti-platelet regimens have been proposed following percutaneous coronary intervention (PCI). In this analys...
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Chen Ning, Fang Ling, Deyi Liu and Zhang Zhi Tags: Research Source Type: research
More News: Angioplasty | Aspirin | Cardiology | Cardiovascular | Coronary Angioplasty | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Percutaneous Coronary Intervention